Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 260

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 260
---
)Prepayments and other current assets(18,729)12,246 (19,258)Long-term deposits(75)187 (527)Value added tax recoverable(1,367)— 22,781 Accounts payable(2,209)36,803 (53,773)Other current liabilities(22,022)19,810 7,392 Operating lease liabilities(9,259)(8,351)(8,455)Deferred income6,588 11,181 (1,379)Other non-current liabilities— 325 — Net cash used in operating activities(214,869)(198,178)(367,642)Cash flows from investing activitiesPurchases of short-term investments(330,000)(134,000)(260,274)Proceeds from maturity of short-term investment16,300 117,700 705,274 Purchases of property and equipment(5,657)(7,212)(24,585)Proceeds from the sale of property and equipment29 122 — Acquisition of intangible assets(55,865)(1,279)(399)Proceeds from sale of intellectual property— 10,000 — Proceeds from disposal of land use right— 3,893 — Net cash (used in) provided by investing activities(375,193)(10,776)420,016 Cash flows from financing activitiesProceeds from short-term debt131,606 — — Repayment of short-term bank borrowings(284)— — Payment of debt issuance cost(700)— — Proceeds from exercises of stock options3,200 2,369 5,870 Proceeds from issuance of ordinary shares upon public offerings217,350 — — Payments of public offering costs(1,283)— — Taxes paid related to settlement of equity awards— (8,802)(7,600)Net cash provided by (used in) financing activities349,889 (6,433)(1,730)Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash(310)(2,622)(6,274)Net (decrease) increase in cash, cash equivalents and restricted cash(240,483)(218,009)44,370 Cash, cash equivalents and restricted cash — beginning of the year791,264 1,009,273 964,903 Cash, cash equivalents and restricted cash — end